LPCN
Price:
$5.15
Market Cap:
$27.54M
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial ...[Read more]
Industry
Biotechnology
IPO Date
2013-10-22
Stock Exchange
NASDAQ
Ticker
LPCN
According to Lipocine Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 12.97. This represents a change of 1.30% compared to the average of 12.80 of the last 4 quarters.
The mean historical Current Ratio of Lipocine Inc. over the last ten years is 10.45. The current 12.97 Current Ratio has changed 12.31% with respect to the historical average. Over the past ten years (40 quarters), LPCN's Current Ratio was at its highest in in the June 2015 quarter at 26.52. The Current Ratio was at its lowest in in the September 2019 quarter at 3.31.
Average
10.45
Median
8.47
Minimum
3.85
Maximum
20.52
Discovering the peaks and valleys of Lipocine Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 146.33%
Maximum Annual Current Ratio = 20.52
Minimum Annual Increase = -80.63%
Minimum Annual Current Ratio = 3.85
Year | Current Ratio | Change |
---|---|---|
2023 | 8.69 | -57.29% |
2022 | 20.34 | 146.33% |
2021 | 8.26 | 114.64% |
2020 | 3.85 | -2.70% |
2019 | 3.95 | -14.65% |
2018 | 4.63 | 16.56% |
2017 | 3.97 | -80.63% |
2016 | 20.52 | 55.07% |
2015 | 13.23 | -22.52% |
2014 | 17.08 | -52.38% |
The current Current Ratio of Lipocine Inc. (LPCN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.43
5-year avg
9.02
10-year avg
10.45
Lipocine Inc.’s Current Ratio is greater than Sigilon Therapeutics, Inc. (2.40), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than ZyVersa Therapeutics, Inc. (0.03), greater than Kiromic BioPharma, Inc. (0.22), greater than Unicycive Therapeutics, Inc. (3.61), greater than Checkpoint Therapeutics, Inc. (0.29), greater than Mustang Bio, Inc. (0.40), greater than Fortress Biotech, Inc. (1.23), greater than Kodiak Sciences Inc. (8.42), greater than Ardelyx, Inc. (4.03), greater than Zura Bio Limited (10.36), greater than Hepion Pharmaceuticals, Inc. (1.30), less than AVROBIO, Inc. (26.17), greater than Verastem, Inc. (3.23), less than Reviva Pharmaceuticals Holdings, Inc. (0), greater than Eyenovia, Inc. (0.41), greater than Cognition Therapeutics, Inc. (0.74), greater than TransCode Therapeutics, Inc. (2.11), greater than null (1.58),
Company | Current Ratio | Market cap |
---|---|---|
2.40 | $56.22M | |
0.41 | $38.12M | |
0.03 | $2.65M | |
0.22 | $1.69M | |
3.61 | $55.01M | |
0.29 | $180.50M | |
0.40 | $9.63M | |
1.23 | $42.11M | |
8.42 | $325.74M | |
4.03 | $1.26B | |
10.36 | $178.25M | |
1.30 | $4.62M | |
26.17 | $5.24M | |
3.23 | $178.03M | |
0 | $40.63M | |
0.41 | $9.30M | |
0.74 | $17.77M | |
2.11 | $6.64M | |
1.58 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Lipocine Inc.'s Current Ratio?
How is the Current Ratio calculated for Lipocine Inc. (LPCN)?
What is the highest Current Ratio for Lipocine Inc. (LPCN)?
What is the 3-year average Current Ratio for Lipocine Inc. (LPCN)?
What is the 5-year average Current Ratio for Lipocine Inc. (LPCN)?
How does the current Current Ratio for Lipocine Inc. (LPCN) compare to its historical average?